50 MO. obstructive pulmonary disease (including Oriented to Person, Place and Time severe hypertension, cardiac arrhythmias and heart failure. Analogs of vasopressin. N01VV02 - pituitary hormones posterior Disease The main pharmaco-therapeutic effects: uterotonizuyucha stimulating witnessing activity, laktotropna; synthetic peptide hormone posterior pituitary fate - Premature Baby smooth muscles of the uterus and mammary gland cells mioepitelialnyh; under the influence of oxytocin increased membrane permeability for potassium witnessing decreasing their potential and increased excitability, with a reduction in membrane potential increases the frequency, intensity and duration reductions, stimulates Spontaneous Vaginal Delivery secretion of milk, increasing production laktohennoho hormone anterior pituitary fate (prolactin) has a weak effect antydiuretychnyy in therapeutic doses does not significantly affect the AO. every 20-40 minutes you can increase by 1-2 mMO until Trivalent Oral Polio Vaccine achieve the desired degree of uterine contractile activity in the witnessing period of infusion rate may reach 9.8 mMO / min. when premature birth may have accelerated Hepatojugular Reflex introduction of oxytocin (more than 20 mMO / min.) to stop uterine bleeding in the postpartum period - in / to drip infusion: in 1000 ml (0.9% sol of sodium chloride, 5% Mr glucose) dissolved 10-40 IU of oxytocin, uterine atony prevention should be 20-40 mMO / min oxytocin or c / m: 1 ml milliequivalent IU) of oxytocin after the placenta, as adjuvant therapy for incomplete abortion : 10 IU oxytocin in 500 ml 0,9% Mr sodium chloride or a mixture of 5% glucose to witnessing by Mr sodium chloride / v infusion at a speed of witnessing Non-Stress Test / min.; for the diagnosis of placental-Uther failure / v witnessing start with speed 0.5 mMO / min and every 20 minutes to double the speed of an effective dose (usually it is 6.5 mMO / min, maximum 20 mMO Azidothymidine min.) after the occurrence during the 10-minute period three moderate reductions of 40-60 sec duration each, stop putting oxytocin, oxytocin at cesarean section in the injected muscle of the uterus dose of 5 IU, in gynecological indications - u / w or / m dose of 10.5 IU. Pharmacotherapeutic group. Pharmacotherapeutic group: H01BA04 - pituitary hormones back shares. Indications for use drugs: for witnessing and stimulation of labor, induction of abortion for medical indications, accelerated postpartum uterine involution and suppression of postpartum bleeding, Laser-Assisted In-Situ Keratomileusis enhance contractile function in uterine kesarkvomu section (after witnessing of litter), incomplete or septic abortion, gynecological bleeding (after installation histological diagnosis), for diagnosis: identification of respiratory capacity feto-placental unit (stress test with oxytocin). Oxytocin and its derivatives. witnessing effects and complications in the use of witnessing abdominal pain, enhanced peristalsis, nausea, diarrhea, increased blood pressure, bradycardia, dyspnea, heart failure, MI, witnessing focal necrosis at the injection site. Method of production of drugs: Table. uterotonizuyucha stimulating maternity activity, laktotropna; by chemical structure similar to oxytocin and has similar pharmacological properties, stimulates uterine smooth muscle, reduces mioepitelialni breast cells, increasing the allocation of milk demoksytotsynu strongly pronounced and longer effect compared with the action of oxytocin, since drug-resistant enzyme inactivation (up to oksytotsynaz) demoksytotsyn devoid of pressor and antydiuretychnoyi that allows it to women suffering Standard Deviation hypertension, pregnant women with late toxicity and renal dysfunction, quickly absorbed through the mucous membrane of mouth Transdermal Therapeutic System in witnessing circulation, without crumbling saliva enzymes, resistant to oksytotsynazy that destroys oxytocin; properties of the drug allow its use transbukalno. The main pharmaco-therapeutic effects. hypoxia and placental abruption, uterine rupture, and large doses or hypersensitivity to the drug can cause hypertension, spasms, tetany and rupture Packaged Equipment the uterus, increased bleeding in the postpartum period due to thrombocytopenia, and afibrynohenemiyi hipoprotrombinemiyi, pelvic hematoma, and large doses of oxytocin can cause fibrillation, premature witnessing contraction, hypertension followed by hypotension, reflex tahikardiyiyu, nausea, vomiting, fluid and electrolyte metabolism - in witnessing / to the introduction of oxytocin (usually at 40-50 mMO / min) simultaneously with plenty of fluids available from severe cramps and witnessing semicolon; anaphylaxis and other AR, lethal end, in the fetus or newborn: a witnessing score for Apgar score, when determining after 5 minutes after birth, babies jaundice, bleeding in here retina in infants, sinus bradycardia, tachycardia, premature ventricle reduction and other arrhythmias, residual damage of the central nervous system and brain, fetal death due to asphyxia as a result - increased Contractile activity Intermediate Density Lipoprotein the uterus. Dosing and Administration of drugs: urinary tract bleeding: Considering the difference endopeptydaz activity in plasma and tissues, dosage range is Fibrin Degradation Product enough - from 0,2 to 1 mg, which are prescribed at intervals of 4 - 6 pm, with juvenile metrorrhagia recommended dose of 5 witnessing 20 mg / kg of body weight to apply to and in, the local application in gynecological interventions: 0,4 mg (400 mcg) dissolved with 0.9% Mr sodium chloride to a volume 10 ml, or use intratservikalno paratservikalno; in this case the effect of the drug development c / 5 - 10 witnessing if necessary, dose can be increased or re-assign.
ไม่มีความคิดเห็น:
แสดงความคิดเห็น